Skip to main content

This is a preprint.

It has not yet been peer reviewed by a journal.

The National Library of Medicine is running a pilot to include preprints that result from research funded by NIH in PMC and PubMed.

medRxiv logoLink to medRxiv
[Preprint]. 2026 Apr 8:2026.03.31.26349338. [Version 1] doi: 10.64898/2026.03.31.26349338

Age-dependent acceleration of structural brain aging in medication-free major depressive disorder linked to neuroanatomical phenotype findings from COORDINATE-MDD consortium

Bhanu Sharma, Pedro L Ballester, Luciano Minuzzi, Wenyi Xiao, Mathilde Antoniades, Dhivya Srinivasan, Guray Erus, Jose A Garcia, Yong Fan, Danilo Arnone, Stephen R Arnott, Taolin Chen, Ki Sueng Choi, Katharine Dunlop, Cherise Chin Fatt, Rachel D Woodham, Beata R Godlewska, Stefanie Hassel, Keith Ho, Andrew M McIntosh, Kun Qin, Susan Rotzinger, Matthew D Sacchet, Jonathan Savitz, Haochang Shou, Ashish Singh, Vibe G Frokjaer, Melanie Ganz, Aleks Stolicyn, Irina Strigo, Duygu Tosun, Dongtao Wei, Ian M Anderson, W Edward Craighead, J F William Deakin, Boadie W Dunlop, Rebecca Elliott, Qiyong Gong, Ian H Gotlib, Catherine J Harmer, Sidney H Kennedy, Gitte M Knudsen, Helen S Mayberg, Martin P Paulus, Jiang Qiu, Madhukar H Trivedi, Heather C Whalley, Chao-Gan Yan, Allan H Young, Christos Davatzikos, Cynthia H Y Fu, Benicio N Frey
PMCID: PMC13086121  PMID: 42006788

ABSTRACT

Background

Major depressive disorder (MDD) is associated with altered brain structure and evidence of accelerated brain aging. However, previous studies have been limited by clinical samples with mixed medication status and multiple mood states, modest sample sizes, small percentage of MDD individuals older than 65 years of age, and/or reliance on summary-level data.

Methods

Harmonized T1-weighted MRI from MDD (n = 645), all medication-free and in a current depressive episode, and matched healthy controls (n = 645), segmented into 145 regional volumes, from 11 sites in COORDINATE-MDD consortium. Brain age gap (BAG) was estimated using gradient boosting regression with nested cross-validation. Group differences in BAG (and age-corrected BAG [cBAG]) were examined across age strata. Regional contributions were evaluated using Shapley Additive exPlanations.

Results

MDD was associated with significantly elevated cBAG compared with healthy controls (mean difference + 2.01 years). Age-stratified analyses showed no differences before mid-30s, with progressively larger gaps thereafter, reaching +6.85 years in MDD aged 55 and older. cBAG differed across neuroanatomical phenotypes associated with differential antidepressant response, cognitive impairment, increased adverse life events, increased self-harm and suicide attempts, and a pro-atherogenic metabolic profile. Key contributing regions included lateral and medial prefrontal regions, middle temporal gyrus, putamen, supplementary motor cortex, central operculum, and cerebellum.

Conclusions

Accelerated structural brain aging in MDD is age-dependent and is most pronounced in a neuroanatomical phenotype associated with worse key clinical outcomes. The findings support neuroprogression models of MDD while demonstrating that cBAG is not a uniform feature of MDD and seem to be more strongly expressed in a specifically clinically vulnerable disease phenotype.

Full Text Availability

The license terms selected by the author(s) for this preprint version do not permit archiving in PMC. The full text is available from the preprint server.


Articles from medRxiv are provided here courtesy of Cold Spring Harbor Laboratory Preprints

RESOURCES